Molnupiravir (Lagevrio)


Indications

COVID-19

MOVe-OUT Trial


Pharmacology

Metabolism


Administration

Dose Adjustment

Use in Pregnancy (see Pregnancy)

Use During Breast Feeding


Adverse Effects

Other Adverse Effects


References